Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice
Sonia Burgaz, Concepción García, María Gómez‐Cañas, Carmen Navarrete, Adela García‐Martín, Alain Rolland, Carmen del Río, Marı́a José Casarejos, Eva Muñoz, Claudia Gonzalo‐Consuegra, Eduardo Muñóz, Javier Fernández‐Ruíz
Topics & Concepts
NeuroprotectionHydroxydopamineBiologyPharmacologyReceptorCannabinoidNeurotoxinCannabinoid receptorInternal medicineBiochemistryEndocrinologyAntagonistDopamineMedicineDopaminergicCannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments